New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Biosensor detects brain tumors with less than a drop of blood

Biosensor detects brain tumors with less than a drop of blood

byAmerican Chemical SocietyGraphical abstract. Credit:ACS Nano(2022). DOI: 10.1021/acsnano.2c04187Despite significant advances, mortality from brain tumors remains high with five-yea
Oncology January 04,2024
Biosensor detects brain tumors with less than a drop of blood

Biosensor detects brain tumors with less than a drop of blood

byAmerican Chemical SocietyGraphical abstract. Credit:ACS Nano(2022). DOI: 10.1021/acsnano.2c04187Despite significant advances, mortality from brain tumors remains high with five-yea
Oncology January 04,2024
Biomarkers show promise for identifying early risk of pancreatic cancer

Biomarkers show promise for identifying early risk of pancreatic cancer

byDuke University Medical CenterCredit: Pixabay/CC0 Public DomainA research team at Duke Health has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are l
Oncology January 04,2024
Biomarkers show promise for identifying early risk of pancreatic cancer

Biomarkers show promise for identifying early risk of pancreatic cancer

byDuke University Medical CenterCredit: Pixabay/CC0 Public DomainA research team at Duke Health has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are l
Oncology January 04,2024
Biomarker-driven protocol model broadens lung cancer trial access for some underrepresented groups

Biomarker-driven protocol model broadens lung cancer trial access for some underrepresented groups

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAs compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cance
Oncology January 04,2024
Biomarker-driven protocol model broadens lung cancer trial access for some underrepresented groups

Biomarker-driven protocol model broadens lung cancer trial access for some underrepresented groups

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAs compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cance
Oncology January 04,2024
The origin-of-life molecule, a key to cancer research

The origin-of-life molecule, a key to cancer research

byUniversity of SevilleSchematic model of the regulation and role of RNAPII-generated nascent RNA to guide DNA end resection and DSB repair by HR. Credit:Nature Communications(2022).
Oncology January 04,2024
The origin-of-life molecule, a key to cancer research

The origin-of-life molecule, a key to cancer research

byUniversity of SevilleSchematic model of the regulation and role of RNAPII-generated nascent RNA to guide DNA end resection and DSB repair by HR. Credit:Nature Communications(2022).
Oncology January 04,2024
Oncology therapy at the end-of-life: Have we missed the mark?

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and
Oncology January 04,2024
Oncology therapy at the end-of-life: Have we missed the mark?

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and
Oncology January 04,2024
Does living along the US-Mexico border affect the chances of survival among children with leukemia?

Does living along the US-Mexico border affect the chances of survival among children with leukemia?

byWileyCredit: Unsplash/CC0 Public DomainResiding in border regions was linked with a higher risk of dying within five years among children with acute lymphoblastic leukemia, the most common typ
Oncology January 04,2024
Does living along the US-Mexico border affect the chances of survival among children with leukemia?

Does living along the US-Mexico border affect the chances of survival among children with leukemia?

byWileyCredit: Unsplash/CC0 Public DomainResiding in border regions was linked with a higher risk of dying within five years among children with acute lymphoblastic leukemia, the most common typ
Oncology January 04,2024
Biochemists, cancer biologists find key vulnerability in rare brain tumors

Biochemists, cancer biologists find key vulnerability in rare brain tumors

by Anne Manning,Colorado State UniversityCredit: Pixabay/CC0 Public DomainSince the start of her career, Jennifer DeLuca has been fascinated by mitosis, the everyday biological process of cell d
Oncology January 04,2024
Biochemists, cancer biologists find key vulnerability in rare brain tumors

Biochemists, cancer biologists find key vulnerability in rare brain tumors

by Anne Manning,Colorado State UniversityCredit: Pixabay/CC0 Public DomainSince the start of her career, Jennifer DeLuca has been fascinated by mitosis, the everyday biological process of cell d
Oncology January 04,2024
Renal impairment linked to worse prognosis in IgD multiple myeloma

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no
Oncology January 04,2024
Renal impairment linked to worse prognosis in IgD multiple myeloma

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no
Oncology January 04,2024
First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of
Oncology January 04,2024
First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of
Oncology January 04,2024
Neuronal molecule makes prostate cancer more aggressive

Neuronal molecule makes prostate cancer more aggressive

byThomas Jefferson UniversityCredit: Unsplash/CC0 Public DomainProstate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers
Oncology January 04,2024
Neuronal molecule makes prostate cancer more aggressive

Neuronal molecule makes prostate cancer more aggressive

byThomas Jefferson UniversityCredit: Unsplash/CC0 Public DomainProstate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers
Oncology January 04,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com